Get All Access for FREE

Market News & Research,
Fundamental Data,
Live Transcripts & Audio,
AlphaGraphics,

and a whole lot more…

{{::item.ticker}} • {{::item.company_name}} No Results

Get All Access for FREE

Market News & Research,
Fundamental Data,
Live Transcripts & Audio,
AlphaGraphics,

and a whole lot more…

News & Research
Portfolio
Discover
Groups
$SIAL {{ '2015-06-24T17:49:53+0000' | timeago}} • SEC

$SIAL 1Q15 10-Q: Quarter-end cash and cash equivalents were $887MM vs. $727MM at 1Q14. Long-term debt was $300MM. Total debt decreased $145MM since Dec. 31, 2014 as a result of the repayment of notes payable under our commercial paper program.

$CLX {{ '2018-02-02T14:10:56+0000' | timeago}} • Infographic

$CLX The Clorox Company Earnings AlphaGraphic: Q2 2018 Highlights

$WST {{ '2017-12-22T12:59:41+0000' | timeago}} • Announcement

$WST BoD approved 1Q18 dividend of $0.14 per share. The dividend will be paid on February 1, 2018, to shareholders of record as of January 18, 2018.

$CSL {{ '2017-12-13T15:11:34+0000' | timeago}} • Announcement

$CSL announced that Jesse Singh, Chief Executive Officer of CPG International, has been elected to its Board of Directors, effective immediately.

$RAVN {{ '2017-12-07T14:15:36+0000' | timeago}} • Announcement

$RAVN appointed Rick Parod to the company's BoD, effective immediately. Mr. Parod served as President, CEO, and Director of $LNN from 2000 until his retirement in December 2017.

$RAVN {{ '2017-12-05T15:08:04+0000' | timeago}} • Infographic

$RAVN's BoD approved $25MM in stock repurchase authorization. With this additional authorization, $RAVN will have about $28MM remaining in its stock repurchase program. The board also approved a regular quarterly cash dividend of 13 cents a share, payable on Jan. 26, 2018 to shareholders of record on Jan. 12, 2018.

$LZB {{ '2017-12-01T12:16:54+0000' | timeago}} • Webcast

$LZB stated that with respect to its 4-4-5 store build-out program for FY18, the company expects executing approx. 25 store projects across the network between the company and its independent dealers. $LZB also expects to end FY18 with 354 stores which would include seven net new stores in 2017.

$LZB {{ '2017-11-30T14:19:56+0000' | timeago}} • Infographic

$LZB La-Z-Boy, Inc. Earnings AlphaGraphics: Q2 2018 Highlights

$LZB {{ '2017-11-29T22:01:45+0000' | timeago}} • Announcement

For FY18, $LZB expects a total of 148 company-owned stores, with dealer-owned stores projected to reach a total of 206 stores. Additionally, the company expects to remodel seven dealer-owned stores and relocate five stores in FY18.

$LZB {{ '2017-11-29T21:56:21+0000' | timeago}} • Announcement

Recliner manufacturer $LZB reported a 2Q18 profit jump of 10% on increased revenue. Net income jumped to $22.89MM or $0.47 per share from the year ago net income of $20.8MM or $0.42 per share. Revenue for the quarter rose 4.4% to $393.2MM. Same-store written sales for the company's Furniture Galleries network increased 1.9%.

$CLX {{ '2017-11-28T21:58:20+0000' | timeago}} • Announcement

$CLX announced the official opening of a new manufacturing facility for the company's Home Care products. Named Atlanta West, the 258,000-sq.ft. facility is adjacent to the company's existing manufacturing facility, called Atlanta Main. The opening of Atlanta West has created about 100 jobs in Clayton County.

$ASH {{ '2017-11-28T15:04:24+0000' | timeago}} • Announcement

$ASH is combining its nutrition business with the ingredients processing expertise of the recently-acquired Pharmachem with the goal of expanding into the fast-growing global nutraceuticals market. The combined unit, which will be called Health and Wellness, will continue to report up through $ASH’s Specialty Ingredients segment.

$ASH {{ '2017-11-28T14:08:36+0000' | timeago}} • Announcement

$ASH plans to nominate Jerome Peribere as a new independent director for election at its upcoming 2018 Annual Meeting. If elected, it is also intended that Peribere will serve as a member of the compensation committee. George Schaefer Jr. will not be nominated for re-election to the board.

$RAVN {{ '2017-11-20T23:13:14+0000' | timeago}} • Announcement

During 3Q18, $RAVN launched an initiative called Project Atlas. This is a strategic long-term investment to replace the existing enterprise resource planning platforms. Project Atlas is expected to take approx. three years to complete and cost between $8-10MM. In 3Q18, Project Atlas costs were approx. $300,000.

$RAVN {{ '2017-11-20T23:07:13+0000' | timeago}} • Announcement

$RAVN reported net income of $12MM or $0.33 per share in 3Q18 versus $5.7MM or $0.16 per share in 3Q17. The increase in EPS was driven primarily by the improved operating performance in both Engineered Films and Aerostar. The impact of the CLI acquisition was neutral to EPS in 3Q18. Net sales were $101.3MM, up 39.7% versus last year.

$CLX {{ '2017-11-15T12:11:07+0000' | timeago}} • Announcement

$CLX declared a quarterly dividend of $0.84 per share on the company's common stock, payable Feb. 9, 2018, to stockholders of record as of the close of business on Jan. 24, 2018.

$LEG {{ '2017-11-07T18:09:33+0000' | timeago}} • Announcement

$LEG's BoD declared a 4Q17 dividend of $0.36 per share. This is an increase of 5.9% versus 4Q16. The dividend will be paid on Jan. 12, 2018 to shareholders of record on Dec. 15, 2017.

$CSL {{ '2017-11-06T17:35:05+0000' | timeago}} • Announcement

$CSL's BoD declared a regular quarterly dividend of $0.37 per share. The dividend is payable on Dec. 1, 2017 to shareholders of record at the close of business on Nov. 17, 2017.

$CLX {{ '2017-11-01T20:52:02+0000' | timeago}} • Infographic

$CLX The Clorox Company Earnings AlphaGraphics: Q1 2018 highlights

$LEG {{ '2017-10-27T18:19:27+0000' | timeago}} • Infographic

$LEG Leggett & Platt Earnings AlphaGraphic: Q3 2017 Highlights

$WST {{ '2017-10-10T13:49:06+0000' | timeago}} • Announcement

$WST, a pharmaceutical services firm, said a recent study showed its injection guide ID Adaptor could be used for administering intradermal injections in a safe and effective manner. The clinical trial evaluated the feasibility of conducting a door-to-door vaccination campaign to administer Fractional Inactivated Poliovirus Vaccine to children.

Recent Transcripts
LYTS | Earnings
January 23rd 2019, 7:00pm
SCHN | Earnings
January 9th 2019, 4:30pm
LZB | Earnings
November 29th 2018, 1:30pm
MDWD | Earnings
November 13th 2018, 1:30pm
AlphaGraphics you may like
Related Feed
Recent Transcripts
LYTS | Earnings
January 23rd 2019, 7:00pm
SCHN | Earnings
January 9th 2019, 4:30pm
LZB | Earnings
November 29th 2018, 1:30pm
MDWD | Earnings
November 13th 2018, 1:30pm
AlphaGraphics you may like